Regulation of dendritic cells by estrogen receptors during influenza infection
流感感染期间雌激素受体对树突状细胞的调节
基本信息
- 批准号:8197771
- 负责人:
- 金额:$ 20.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-12-01 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdjuvantAdultAffectAntigen PresentationAntiviral ResponseBiologyBone MarrowCellsCompetenceCytokine ActivationDataDendritic CellsDevelopmentEndocrineEnvironmentEnvironmental Risk FactorEquilibriumEstradiolEstrogen Receptor alphaEstrogen ReceptorsEstrogensExhibitsFemaleGonadal Steroid HormonesGranulocyte-Macrophage Colony-Stimulating FactorHormone ReceptorHumanITGAM geneITGAX geneImmuneImmune responseImmune systemImmunizationInfectionInflammatoryInfluenzaInfluenza A Virus, H1N1 SubtypeInterferon Regulatory Factor 4Interferon Type IKnowledgeLeadLigandsLungMediastinal lymph node groupMediatingModelingMolecularMorbidity - disease rateMusMyelogenousOrganOutcomePathway interactionsPhysiologicalPopulationPredispositionPrevalenceProcessProductionReceptor SignalingRegulationRelative (related person)RodentRodent ModelSeveritiesSex BiasSex CharacteristicsSignal TransductionTestingTissuesToll-like receptorsVariantVirusVirus DiseasesWomanWorkabstractingcell mediated immune responsecytokinein vivoinfluenzavirusinnovationinsightlymph nodesmalemenmonocytemortalitynovelpandemic diseaseprogenitorpublic health relevanceresponsesextranscription factor
项目摘要
DESCRIPTION (provided by applicant): Regulation of dendritic cells by estrogen receptors during influenza infection Abstract Influenza virus infections result in significant morbidity and mortality in the human population, and the recent H1N1 pandemic underscores the need to understand the physiological and environmental risk factors that regulate the human variation in immune responses to influenza virus. This project will determine how one such physiological factor, estrogen receptor alpha (ER1) signaling, regulates the innate immune response to influenza virus infection in mice. Although humans and rodents often exhibit marked sex differences in the prevalence and severity of infection, little is known about the molecular mechanisms by which these sex differences occur and if they are mediated through effects of sex hormones on the innate immune responses elaborated by monocytes and dendritic cells (DC). The functional importance of newly developed populations of inflammatory and tissue DC in the lung and mediastinal lymph nodes during murine influenza infection has recently been elucidated. We have shown that estradiol/ER1 signaling promotes the GM-CSF-driven inflammatory pathway that leads to development of CD11b+ DC. These DC have features of the tissue and inflammatory DC that are crucial during influenza infection. Our data also show that ER1 signaling modulates the activation and function of mature DC. In this project, we will test the hypothesis that during influenza infection, the de novo development and function of DC are regulated by ER1 signaling in response to normal endogenous levels of estrogens. We will evaluate two distinct mechanisms by which ER1 signaling might influence DC-mediated immune responses during infection in vivo: (1) regulation of de novo DC development from inflammatory monocytes or other DC precursors, and (2) regulation of the functional responses of mature DC. We will address these questions using innovative models that include competitive ER1+/ER1-/- bone marrow chimeric mice and mice in which ER1 deficiency is restricted to DC. These novel models will lead to new insights into how ER1 signaling in response to physiological levels of endogenous estrogens regulates de novo DC development and functional responses during influenza virus infection in both sexes.
PUBLIC HEALTH RELEVANCE: Cells of the human and murine immune systems are capable of responding to natural estrogens. We seek to understand how estrogens control the development and function of key regulatory cells of the immune system, termed dendritic cells, during influenza virus infection. This knowledge will determine how natural estrogen levels regulate the immune response during influenza infection and help elucidate why men and women differ in susceptibility to viral infections.
描述(由申请人提供):在流感感染期间雌激素受体对树突状细胞的调节摘要流感病毒感染导致人群中显著的发病率和死亡率,并且最近的H1N1大流行强调了理解调节人类对流感病毒的免疫应答变化的生理和环境风险因素的需要。该项目将确定一个这样的生理因素,雌激素受体α(ER 1)信号传导,如何调节小鼠对流感病毒感染的先天免疫反应。虽然人类和啮齿类动物经常表现出显着的性别差异的感染的患病率和严重程度,很少有人知道这些性别差异发生的分子机制,如果他们介导的先天免疫反应的单核细胞和树突状细胞(DC)的性激素的影响。最近已经阐明了在鼠流感感染期间肺和纵隔淋巴结中新开发的炎性和组织DC群体的功能重要性。我们已经证明,雌二醇/ER 1信号促进GM-CSF驱动的炎症通路,导致CD 11b + DC的发展。这些DC具有在流感感染期间至关重要的组织和炎性DC的特征。我们的数据还表明,ER 1信号调节成熟DC的激活和功能。在这个项目中,我们将测试的假设,在流感感染期间,从头发展和功能的DC调节ER 1信号在响应正常的内源性雌激素水平。我们将评估两种不同的机制,其中ER 1信号可能会影响DC介导的免疫反应在体内感染过程中:(1)调节从头DC发展的炎症单核细胞或其他DC前体,和(2)调节成熟DC的功能反应。我们将使用包括竞争性ER 1 +/ER 1-/-骨髓嵌合小鼠和ER 1缺陷仅限于DC的小鼠的创新模型来解决这些问题。这些新的模型将导致新的见解如何ER 1信号在响应生理水平的内源性雌激素调节从头DC的发展和功能反应在两性流感病毒感染。
公共卫生相关性:人类和小鼠免疫系统的细胞能够对天然雌激素做出反应。我们试图了解在流感病毒感染期间雌激素如何控制免疫系统的关键调节细胞(称为树突状细胞)的发育和功能。这些知识将确定天然雌激素水平如何调节流感感染期间的免疫反应,并有助于阐明为什么男性和女性对病毒感染的易感性不同。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells.
- DOI:10.4049/jimmunol.1501870
- 发表时间:2016-02-15
- 期刊:
- 影响因子:0
- 作者:Bajaña S;Turner S;Paul J;Ainsua-Enrich E;Kovats S
- 通讯作者:Kovats S
Girl power: estrogen promotes HSC self-renewal.
- DOI:10.1016/j.stem.2014.01.016
- 发表时间:2014-02-06
- 期刊:
- 影响因子:23.9
- 作者:Carreras, Esther;Kovats, Susan
- 通讯作者:Kovats, Susan
Estrogen receptors regulate innate immune cells and signaling pathways.
- DOI:10.1016/j.cellimm.2015.01.018
- 发表时间:2015-04
- 期刊:
- 影响因子:4.3
- 作者:Kovats S
- 通讯作者:Kovats S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan Kovats其他文献
Susan Kovats的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan Kovats', 18)}}的其他基金
IRF4-Mediated Regulation of Lung Dendritic Cells During Viral Infection
病毒感染期间 IRF4 介导的肺树突状细胞调节
- 批准号:
8916820 - 财政年份:2014
- 资助金额:
$ 20.38万 - 项目类别:
IRF4-Mediated Regulation of Lung Dendritic Cells During Viral Infection
病毒感染期间 IRF4 介导的肺树突状细胞调节
- 批准号:
8760146 - 财政年份:2014
- 资助金额:
$ 20.38万 - 项目类别:
IRF4-Mediated Regulation of Lung Dendritic Cells During Viral Infection
病毒感染期间 IRF4 介导的肺树突状细胞调节
- 批准号:
9114154 - 财政年份:2014
- 资助金额:
$ 20.38万 - 项目类别:
Regulation of dendritic cells by estrogen receptors during influenza infection
流感感染期间雌激素受体对树突状细胞的调节
- 批准号:
8038623 - 财政年份:2010
- 资助金额:
$ 20.38万 - 项目类别:
Sex Differences and Estrogen Receptors Regulate Dendritic Cells in Inflammation
性别差异和雌激素受体调节炎症中的树突状细胞
- 批准号:
8128230 - 财政年份:2010
- 资助金额:
$ 20.38万 - 项目类别:
Estrogen Receptor Modulators and Dendritic Cell Function
雌激素受体调节剂和树突状细胞功能
- 批准号:
6986466 - 财政年份:2005
- 资助金额:
$ 20.38万 - 项目类别:
Estrogen Receptor Modulators and Dendritic Cell Function
雌激素受体调节剂和树突状细胞功能
- 批准号:
7140540 - 财政年份:2005
- 资助金额:
$ 20.38万 - 项目类别:
Estrogen Receptor Modulators and Dendritic Cell Function
雌激素受体调节剂和树突状细胞功能
- 批准号:
7197646 - 财政年份:2005
- 资助金额:
$ 20.38万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 20.38万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 20.38万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 20.38万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 20.38万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 20.38万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 20.38万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 20.38万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 20.38万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 20.38万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 20.38万 - 项目类别:
Research Grant














{{item.name}}会员




